The extracorporeal CO 2 removal device (ECCO 2 RD) is used in clinics to treat patients suffering from respiratory failures like acute respiratory distress syndrome (ARDS) or chronic obstructive pulmonary disease (COPD). The aim of this device is to decarboxylate blood externally with low blood flow. A mathematical model is proposed to describe protective ventilation, ARDS, and an extracorporeal CO 2 removal therapy (ECCO 2 RT). The simulations are compared with experimental data carried out on ten pigs. The results show a good agreement between the mathematical simulations and the experimental data, which provides a nice validation of the model. This model is thus able to predict the decrease of PCO 2 during ECCO 2 RT for different blood flows across the extracorporeal lung support.
Introduction
Acute respiratory distress syndrome (ARDS) is still life threatening despite new strategies in mechanical ventilations [8, 18, 28] . Mortality and morbidity of chronic Simon Habran simon.habran@ulg.ac.be 1 GIGA -In Silico Medicine, University of Liege, Liege, Belgium 2 GIGA -Cardiovascular Sciences, University of Liege, Liege, Belgium obstructive pulmonary disease (COPD) are also considerable [7, 34] . For moderate ARDS (PaO 2 /FiO 2 >100 mmHg [10] , where PaO 2 is the arterial partial pressure in O 2 and FiO 2 is the inspired oxygen fraction) or COPD, a small extracorporeal lung support (ECLS), called the extracorporeal CO 2 removal device (ECCO 2 RD), can be used [1, 4, 9, 23, 32, 33 ] (see Fig. 1 ). The aim of such a device is to decrease the CO 2 partial pressure without being too invasive, while the effect on oxygenation remains very low with this configuration. The main difference between an ECCO 2 RD and a larger ECLS used in venovenous extracorporeal membrane oxygenation (vv-ECMO) is the volume of the gas exchanger, which is smaller for ECCO 2 RD. Given the small volume of the gas exchanger in the ECCO 2 RD, the blood flow entering the device must be smaller than 0.8 l/min (see, as an exemple, the ECCO 2 RD of NovaLung [37] ).
The purpose of this paper is to develop and validate a mathematical model of the respiratory system assisted by an ECCO 2 RD to improve the use of this device. More precisely, before starting the extracorporeal CO 2 removal therapy (ECCO 2 RT), it is important to assess the appropriate blood flow that must cross the device for a given patient's status and therapeutic strategy. Indeed, if this blood flow has been determined, clinicians can decide if an ECCO 2 RD can be used instead of a larger ECLS and they can also choose the appropriate cannulae size, which must be kept as small as possible in order to reduce complications, like hemorrhage and infections. Developing a mathematical tool to facilitate this preliminary step of care is the main longterm target of this research. In order to propose solutions adapted to the patient's status, the mathematical model is made as patient-specific as possible given the available data in the intensive care unit (ICU). In addition, the model has [21] to be simple enough to allow real-time parameter identification, but also complex enough to be able to simulate pulmonary abnormalities and the respiratory system when protective ventilation is introduced and when an ECCO 2 RD is switched on.
Scientists have already developed several mathematical models of the respiratory system (lung gas exchange and tissues gas exchange) for many years [3, 12, 35] but these models usually do not take into account pulmonary gas exchange abnormalities like ARDS and COPD. Some authors have proposed modeling these abnormalities by including a perfusion/ventilation mismatch [16] or by decreasing the diffusion across the alveolar capillary membrane [29] . However, very few authors have developed models of the respiratory system connected to an extracorporeal lung support [6, 20, 22, 36] . The models of Walter et al. [36] and Brendel et al. [6] describe lung, tissues, and ECCO 2 RD gas exchange but to account for gas exchange abnormalities in the lung, these authors introduce two purely empirical parameters. The appropriate account of gas exchange abnormalities is of paramount importance in this work and parameters with a clear physiological interpretation are introduced to describe these abnormalities. Moreover, the goal of the authors cited above is different from ours since they use their models in a control algorithm designed to maintain appropriate longterm gas contents of the blood, while our approach will help clinicians determining the best settings of an ECCO 2 RD before it is used.
In the following sections, the different components of the mathematical model are described and the experimental procedures that were carried out on ten pigs are presented. Then the model predictions are compared to the data. Finally, these results are analyzed and discussed.
Methods

Mathematical modeling
The model is a lumped parameter model of the respiratory system connected to an ECCO 2 RD. Besides the ECCO 2 RD, two other compartments are considered: one lung compartment and one tissues compartment (the three compartments are sketched in Fig. 2 ). The equations of the model will not be presented here since the different components were already introduced separately elsewhere. However, for the interested reader, the mathematical model is recalled in Appendix A.
The impairments of pulmonary gas exchange is described by two parameters: f s which describes the importance of the Lung Tissues ECCO 2 RD Fig. 2 Model of pulmonary gas exchange connected to an ECCO 2 RD. F I,i , C a,i and C v,i are respectively the inspired fraction, the concentration in arteries and the concentration in veins of component i (i = O 2 or CO 2 ). Q c is the mean cardiac blood flow. f s and f d are the fraction of pulmonary blood crossing the shunt and the fraction of blood passing through by the ECCO 2 RD.V D is the ventilation of the ECCO 2 RD anḋ V L is the mean effective ventilation of the lungs. The other symbols are defined in Appendix A pulmonary shunt (this parameter is also used in the works of Kabring et al. [16] and of Rees et al. [29] ) andV L which is the mean effective ventilation (the ventilation that actually participates in gas exchange). In addition, the production of CO 2 (MR CO 2 ) and the consumption of O 2 (MR O 2 ) by metabolism are two important parameters for the appropriate description of the respiratory system. The values of these four parameters are estimated for each subject as explained in Section 2.3.2.
An appropriate blood chemistry model is also needed. In the present work, the relation between O 2 concentration and O 2 partial pressure PO 2 follows the equations of Grodins et al. [12] and the relation between total CO 2 concentration C CO 2 , pH in blood plasma and CO 2 partial pressure P CO 2 follows the equations of Trueb et al. [35] . Note however that in the C CO 2 -P CO 2 relation, a correction term k HCO 3 must be introduced to account for variations in standard HCO 3 concentration between individuals (more details are provided in Section 2.3.1).
Experimental data
Two sets of retrospective experiments (approved by the Ethics Committee of the Medical Faculty of the University of Liège) including an ECCO 2 RD are used to validate the mathematical model. The first set of experiments, that are referred to as experiments H in the text below, are carried out on four healthy pigs, named H1 to H4, subject to protective ventilation. For the six animals, A1 to A6 of experiments A, ARDS is induced in addition to protective ventilation (for the detailed protocol of the induction of ARDS, see Morimont et al. [24] ). Pigs have been chosen for the animal trials because their cardiovascular and respiratory physiology are similar to human.
At the beginning of both sets of experiments, the pigs are anesthetized and intubated. After a 30-min stabilization period, whose end defines the baseline situation, several experimental data (blood flow, CO 2 and O 2 concentrations in venous and arterial blood samples) are measured and the settings of the ventilator are also recorded. Then protective ventilation is introduced for about 45 min. In experiments A, ARDS is induced during this phase of the protocol by the normal saline lavage method [24] . After that, the ECCO 2 RD (PALP , Mitched on to remove the excess CO 2 . In all experiments, the gas flow through the device is set to 10 L of atmospheric air per minute. The blood flow in the ECCO 2 RD is fixed to several values, which are specified in the results section.
The body blood flow is measured with thermodilution technique (PiCCO , Pulsion, Germany) and also with an admittance pressure-volume catheter (Transonic , USA) in the right ventricle. Tidal volume, FiO 2 , respiratory frequency and driving pressure are fixed by the ventilator (Engström Carestation , General Electric, Germany) and note that FiCO 2 is always equal to 0. Arterial and venous blood samples are analyzed during the experimentation with a RapidPoint500 device (Siemens, Germany). In experiments H, additional blood samples are analyzed at the inlet and outlet cannulae and the gas exiting the ECCO 2 RD is also analyzed with a CARBOCAP device (Vaisala, Finland) .
Note that the two sets of experiments are important for the purpose of this work since they complement one another. Experiments H are needed because more data is available and the estimation of all the parameters of the model is feasible. However, the model must also be validated in case of gas exchange abnormalities. Therefore, experiments A are also needed since an ARDS is induced.
Estimation of the parameters
As already mentioned in Section 2.1, several parameters describe the patient's status (in this case the animal's status) and must be estimated with several measurements. These parameters are thus subject-specific and their estimation is of course crucial. The parameters related to the blood chemistry are considered in the first subsection below while those related to the lungs and tissues compartments are discussed in the second subsection. These parameters are estimated for each pig and their values will be given in Section 3. Other parameters, which are not subject specific, must also be considered in the mathematical model and are described in the Appendix A.5. Some of these parameters are taken from the literature and are derived from human study. These parameter values are also discussed in the Appendix A. 5 In addition, the value of the diffusion coefficient characterizing the membrane of the ECCO 2 RD is not provided by the manufacturer and this quantity must also be considered as a parameter. Its value is determined by a procedure which is explained in the last subsection below.
Blood chemistry
Quantity k HCO 3 is a subject-specific parameter in the equations of Trueb et al. [35] and it must be evaluated for each pig. Its values is assumed constant in time and can be estimated by using values of pH, P CO 2 and the hemoglobin saturation with O 2 in arteries during baseline situation.
Gas exchange in the lungs and in the tissues
MR CO 2 and MR O 2 describe the CO 2 production and O 2 consumption by the tissue. These parameters are assumed to not be affected by the ventilator settings or by the induction of ARDS. These quantities are thus estimated only at baseline for each animal. Using the values of cardiac output and O 2 concentrations in arterial and venous blood samples in a time-independent situation, parameter MR O 2 can be determined. For the CO 2 production in the tissues, the equality MR CO 2 = MR O 2 is assumed. Note also that the body temperature of the animals is not controlled in our experiments and a significant decrease of the temperature is observed as soon as the ECCO 2 RT is started (blood loses heat in the pipes and in the device). This temperature decrease induces a change in the metabolism and the values of MR CO 2 and MR O 2 have to be modified accordingly (see Appendix B for the details). However, since the temperature of the body is controlled in the ICU, it will not be necessary to take this effect into account in a future application of the mathematical model in clinics.
Parameters f s andV L describe the global efficiency of gas exchange in the lungs and their estimation is very important. To our knowledge, this present approach is unique in the literature since it is the first time that the pulmonary gas exchange abnormalities are described with these two parameters when an ECLS is connected to the respiratory system. The settings of the ventilator (tidal volume and respiratory frequency) and ARDS notably influence the gas exchange. The parameters f s andV L must be thus reevaluated each time these settings are modified and after the induction of ARDS. For this reason, these quantities must be identified twice in both experiments: once during baseline situation and once during protective ventilation (combined with ARDS induction in experiments A). The identification of these parameters is obtained by fitting the measurements of arterial PCO 2 and PO 2 (the venous counterparts being linked to the arterial values by the previously determined MR CO 2 and MR O 2 ) with the corresponding simulated values. During baseline, the system is completely stabilized and the variables are thus time independent. The identification of these parameters is more delicate after introducing the protective ventilation and inducing ARDS. Indeed, this phase of the experiment is usually too short (45 min) to reach a steady state in the respiratory system. In that situation, the fitting of f s andV L is based on the comparison of the measurements and the time evolution obtained from the solution of the differential equations. 2 
Diffusion in the ECCO
RD
The CO 2 exchanges in the ECCO 2 RD is characterized by the CO 2 diffusion coefficient across the synthetic membrane D CO 2 . Its value is independent of the patient's status and of the ventilator settings. It can be obtained by fitting the predictions of the ECCO 2 RD mathematical model with measures of PCO 2 in the inlet and outlet canulae and in the gas flowing out of the device.
For the O 2 diffusion coefficient across the synthetic membrane D O 2 , the measurements of the O 2 fraction in the gas flowing out of the ECCO 2 RD was not available. In addition, the accuracy of measurements in blood is not high enough to estimate D O 2 in our pig experiments. For these reasons, D O 2 is assumed to be 40 times smaller than D CO 2 as is the case for the heart-lung machine described in [22] . This estimation of D O 2 is a bit rough but it is still sufficient for the main purpose of this work. Indeed, this quantity has only a minute influence on the time evolution of PCO 2 , which is the main quantity of interest in this work.
Statistics
The goal of the mathematical model is to predict the decrease of PCO 2 for different blood flows entering the ECCO 2 RD. All parameters are thus estimated before the ECCO 2 RT and the model must be able to describe this therapy without changing any parameter. To test the predictions of the model, the mean difference (| P |) between the simulations and the experimental data is estimated with the following formula:
where n is the number of measurements, P exp i is the PCO 2 measurement i, and P sim i is the corresponding PCO 2 simulated with the model. The mean relative difference (| P /P |) provides another way to estimate the error :
In addition, in order to estimate if the model tends to overestimate or to underestimate the partial pressure, the mean difference and the mean relative difference are also computed without the absolute value (and the corresponding symbols are written as P and P /P ).
Results
In this section, the mathematical model is tested by simulating an ECCO 2 RT and the numerical results of the model are compared to the experimental data obtained in experiments H and experiments A. In the first subsection, the values of the specific parameters corresponding to each animal are given. Then, the results of the simulations are presented.
Values of the parameters
To determine the diffusion coefficients across the membrane of the ECCO 2 RD, we use the data of experiments described in Section 2.3. Note that in Table 1 , parameter f s increases when protective ventilation is induced and it increases even more when protective ventilation is coupled with ARDS. On the other hand, the effective ventilationV L decreases when protective ventilation is induced. Cardiac blood flow values for the different animals during the experiments are also parameters of the model and Fig. 3 provides these values for pigs H2 and A6 for which detailed results are presented below ( Table 2) .
The other parameters, which are not subject specific, are given in Table 3 in Appendix A.5.
Comparison between experimental and numerical results
Using the values of the parameters given above, the mathematical model is able to describe the gas exchange for experiments H and experiments A during the ECCO 2 RT. The main results consist of the time evolution of PCO 2 at several places in the body. Figure 4 illustrates the time evolution of PCO 2 in veins, in the right ventricle and in arteries for pig H2 and Fig. 5 illustrates the time evolution of PCO 2 in veins and in arteries for pig A6. The results for the other pigs are not presented since they present similar features. Note that the error on the measurements is equal to 0.03 × value of the measurement + 0.17 mmHg, according to the results during ECCO 2 RT will be analyzed in detail. During this period, all parameters are kept constant and the agreement between simulations and experimental data remains quite good, for a relatively long period of time. Table 2 provides the mean errors P and the mean relative errors P /P with and without absolute value for each pig of the two sets of experiments. The number of experimental data (# data) is also given. Note that the standard deviation of the errors is not given for experiments A since the number of measurements is small (less than five measurements). One can observe that the errors for experiments H are larger than for experiments A. However, experiments H have more experimental data in different parts of the body (experiments A have only arteries measurements during ECCO 2 RT). For experiments H, the model always underestimates PCO 2 (the value of P and P /P is always negative) whereas underestimations and overestimations are almost as likely for experiments A. In addition, the mean errors are also computed for all pigs (last column) and one can observe that the global relative error | P /P | is equal to 11%. 
Discussion
This section discusses the physiological meaning of important parameters and discusses the ability of our model to predict the decrease of the PCO 2 during ECCO 2 RT. The possible application of the mathematical model in the ICU is also discussed and, finally, the limitations of the model are described.
Modeling of lung gas exchange
Walter et al. [36] and Brendel et al. [6] have already developed a three-compartment mathematical model (lung, tissues, and ECCO 2 RD compartments) similar to that used in our approach. However, the above authors use two empirical parameters to describe pulmonary gas exchange abnormalities. Since the aim of our work is to find parameters specific to a given subject before the ECCO 2 RT is initiated, the description of the possible abnormalities is quite crucial. For this reason, our model uses two parameters with clear physiological meaning to describe the impairments of gas exchange: f s which describes the importance of the pulmonary shunt andV L which is the mean effective ventilation. In the literature, the mean effective ventilationV L is often not identified as in our approach, but directly estimated [17, 29] .V L depends on the tidal volume and the respiratory frequency, which are easily known since they are settings of the ventilator. ButV L also depends on the dead space V Dead , which is much more difficult to obtain. Some authors assume that this space is equal to 150 ml for an adult patient [29] , while others measure the dead space with a stand-alone respiratory monitor [17] . In our experiments on pigs, the assumption of a human value equal to 150 ml can not be made. It is not either possible to estimate V Dead with a gas analyser at the outlet of the ventilator. Indeed, the experimental data related to the CO 2 expired out of the ventilator are not enough precise to estimate the dead space with the small ventilation used in our experiments. Consequently,V L is identified at the same time as the pulmonary shunt f s and these two parameters describe the efficiency of gas exchange in the lungs. Whereas parameter f s describes the fraction of blood that does not participate in gas exchange, parameterV L describes the actual air flux in the lungs. In physiology, the quality of gas exchange in the lungs depends on many factors, such as for example, ventilation-perfusion mismatch or the quality of diffusion across the alveolar-capillary membrane. In the present work, these effects are not explicitly modeled and parameters f s andV L must thus be considered as lumped parameters that allow global description in the mathematical model all the possible anomalies of gas exchange. During the animal experiments, the tidal volume is decreased drastically when the protective ventilation starts.
Of course, the effective ventilation changes with the tidal volume but the pulmonary shunt can also change since the dynamics of the lung is modified. The induction of ARDS has also an impact on the pulmonary shunt. Therefore, it is necessary that the two parameters are estimated twice: first during the baseline situation and then during protective ventilation (combined with ARDS induction in experiments A). The changes of these two parameters between the two phases are discussed in the next subsection. Table 1 shows that the two lumped parameters f s andV L behave as physiologically expected. Indeed, during ARDS, many alveoli do not work properly and the increase of the pulmonary shunt with ARDS is observed in physiology [2, 31] . The value of f s during ARDS (45.7±3.6%) is larger than in previous studies of human ARDS (31±10% [16] ) but note that the experiments are carried out on pigs and that ARDS is not "real" since it is only simulated by injecting water into the lungs. The value of f s at baseline (6.3±0.9%) is also larger than expected for a healthy human (2% [13] ) but the pigs are intubated and anesthetized and thus not in a truly physiologically healthy state. The small increase of f s during protective ventilation for experiments H can be interpreted by the collapse of some alveoli when the pressure in the lungs is lower. With regards to parameterV L , its decrease during protective ventilation is clearly related to the drastic decrease of the tidal volume.
Values of the parameters
MR 
Quality of the PCO 2 prediction
Even if the CO 2 removal therapies considered are rather complex for experiments H, since the settings of the device are changed several times during the period of interest, the model is able to describe the general behavior of the system throughout the whole experiment. The global relative error | P /P | for all pigs of experiments H and experiments A is larger than the accuracy of the blood analyser RapidPoint500 (11% compared to 3%) but the simulation of the PCO 2 prediction depends on several other measurements like the cardiac output, the inspired fraction of O 2 and the PO 2 . In addition, for the simulations, the extracorporeal blood flow is assumed to be perfectly controlled, whereas in reality, it is difficult to achieve that goal. Recall also that the parameters f s andV L are kept constant throughout the ECCO 2 RT and are estimated before ECCO 2 RT. Therefore, we can consider that our mathematical model of the respiratory system connected to an ECCO 2 RD can predict rather nicely the decrease of the PCO 2 during ECCO 2 RT. For this reason, our model can be considered as validated by the pig experiments.
The purpose of the mathematical model is to find an appropriate extracorporeal blood flow for a specific patient. Therefore, it is interesting to know how the 11% relative error on the PCO 2 impacts the prediction of the blood flow. To test the sensitivity of the extracorporeal blood flow with respect to the PCO 2 error, we have considered the "mean pig" of all the experiments. This "mean pig" is obtained by considering the mean of all the parameters given in Table 1 (MR CO 2 = MR O 2 = 0.17 l/min,V L = 1.7 l/min, f s = 0.25% and k HCO 3 = 0.03 l CO 2 /l, F I,O 2 = 0.9 and a weight of 28 kg) and we have used our mathematical model to determine the blood flow that allows to achieve a PCO 2 equal to 50 mmHg in arteries after 1 h of ECCO 2 RT. Then, the blood flows corresponding to 50 + 11% mmHg and 50-11% mmHg is also determined. The situation is illustrated in Fig. 6 and the values of the three blood flows are respectively 268, 199, and 377 ml/min. The positive and negative errors in PCO 2 thus give rise to 26 and 40% of imprecision in the calculated blood flows respectively, which is not negligible but nevertheless acceptable in comparison with the global error of all our experiments. In addition, in a clinical environment, the patients' status is often quite unstable like our pig experiments and it is reasonable to have an uncertainty over the appropriated blood flow.
Application of the model in the ICU
The results show that the mathematical model is able to predict the decrease of PCO 2 during ECCO 2 RT carried out on pigs. This is a very encouraging step for trying to extend the use of this model to the ICU. It could improve care for patients under ECCO 2 RT. In the context of this possible extension of the use of the model, two additional points need to be made. First, recall that in the simulations described in Section 3.2, the cardiac blood flow, which is continuously measured in experiments, is introduced as a given function of time in the calculations. However, if the model is to be used in the ICU before starting the ECCO2RT in order to determine the best settings of the device, the change of cardiac output is of course unknown when the calculations are carried out. To check if this would affect the predictions of the mathematical model, a constant cardiac blood flow is introduced in our calculations and the corresponding mean relative errors between the simulations and the experimental data become 10.7%. This error is the same than the previous one obtained with the time-varying blood flow, which indicates that the predictions are not affected if the blood flow is considered constant. This is of course a very important result for the use of the mathematical model in the ICU.
Second, it is interesting to mention that the time needed for a numerical simulation of PCO 2 decrease during a one hour ECCO 2 RT is around 3 min (on a standard laptop computer and using MATLAB ). This computation time is thus sufficiently small to allow the model to participate in the rapid decision making that is required by clinicians at the patients bedside in the ICU.
Limitations
CO 2 production MR CO 2 and O 2 consumption MR O 2 are two important quantities in the functioning of the respiratory system. These two quantities are equal for carbohydrate metabolism but if the patient's metabolism uses different sources like fats or proteins, MR CO 2 is smaller than MR O 2 [11, 25] . Unfortunately, because the total concentration of CO 2 in the blood depends on three chemical species (CO 2 dissolved in blood, HCO − 3 and CO 2 complexed with hemoglobin), the identification of the value of MR CO 2 from blood sample analyses has proved to be quite delicate and even impossible in our experiments. For this reason, we have introduced the rough approximation of equal MR CO 2 and MR O 2 .
If the long-term purpose of this work is to provide an additional therapeutic tool to clinicians, other limitations must also be emphasized. First, the status of the pigs used in experiments do not exactly correspond to that of humans in the ICU. In the experiments, hypercapnia was induced by protective ventilation and injection of water in the lungs, but no real ARDS or chronic obstructive pulmonary disease was considered. In addition, even if the pig cardiopulmonary system is close to that of human, ICU patients could have different responses to ECCO 2 RT.
Finally, this mathematical model is validated only for a specific ECLS, which is the Maquet ECCO 2 RD (PALP , Germany). Other, and larger ECLS like vv-ECMO, should also be considered. In particular, it is worth mentioning that larger ECLS are also used to oxygenate blood and this work do not consider this possibility.
Conclusions and future works
In this work, a lumped parameter model of the respiratory system connected to an extracorporeal CO 2 removal device (ECCO 2 RD) is built. This device is used to decrease the PCO 2 when a patient suffers from acute respiratory distress syndrome (ARDS) or from chronic obstructive pulmonary disease (COPD). Two parameters are introduced in the model to characterize the possible impairments of gas exchange in the lung. Parameter f s charaterizes the pulmonary shunt and is defined as the fraction of blood flow that does not participate in gas exchange in the lungs. The effective ventilationV L is the ventilation that actually participates in gas exchange. The values of f s andV L are identified from measurements available in the ICU and are patient-specific. In the tissues, production of CO 2 and consumption of O 2 by the metabolism are considered as parameters of the model and are also identified in a patientspecific way. Cardiac output is another important parameter of the model. If all these parameters are identified before the extracorporeal CO 2 removal therapy (ECCO 2 RT), the mathematical model can correctly simulate the decrease of PCO 2 during ECCO 2 RT.
To validate the mathematical model, PCO 2 predictions are compared with experimental results obtained in pigs. The results show that the model is able to reproduce experimental data for quite long periods of time (up to about 150 min for experiments H and up to about 60 min for experiments A) and until a total decarboxylation of blood is reached. The quite good agreement between the theoretical approach and animal data can thus be considered as a strong argument proving the validity of our model.
A next interesting step would be a detailed validation of the model in an ICU environment, using retrospective data corresponding to real human pathologies. After this validation, the model could become a useful tool for determining the most appropriate blood flow that must be sent to the ECCO 2 RD for a given therapeutic strategy and a final PCO 2 -target. Then, the most appropriate and smallest canulae would be determined in order to obtain the expected decarboxylation.
The three compartments of the mathematical model are sketched in Fig. 2 (see Section 2.1) and the corresponding equations are described below.
Our model, which is sketched in Fig. 2 (see section 2.1), is a lumped parameter model of the respiratory system connected to an ECCO 2 RD. Besides the ECCO 2 RD, two other compartments are considered in our model: one lung compartment and one tissues compartment (in which the metabolism of the patient is taken into account). The lung compartment allows the description of pulmonary abnormalities thanks to a pulmonary shunt f s and an effective ventilationV L . In addition, a blood chemistry model is also needed. All the corresponding equations are described below and the estimation of all the parameters are explained in the last subsection.
A.1 Pulmonary gas exchange
Our model of pulmonary gas exchanges is based on the work of Batzel et al. [3] . In their work, the authors consider that diffusion of O 2 and CO 2 is fast so that equilibrium can be assumed between the alveoli and the pulmonary capillaries. The concentrations of O 2 and CO 2 in the alveoli are thus equal to the concentrations in the arteries. This assumption does not hold for gas exchanges abnormalities and this model need to be completed with additional parameters and additional equations. Our model considers two physiological parameters: f s which describes the importance of the pulmonary shunt (like in the work of Kabring et al. [16] and Rees et al. [29] ) andV L which is the mean effective ventilation. In this context, the material balance of CO 2 in the lungs can be written as follows:
where:
is the CO 2 partial pressure in the air contained in the lungs (in mmHg). F L,CO 2 is the corresponding molar fraction of CO 2 in the lungs, P atm (mmHg) is the atmospheric pressure and 47 mmHg is the saturated water vapor pressure at 37 • C, -Q c (l/min) is the cardiac output, -C vd,CO 2 (l CO 2 /l) is the CO 2 concentration in blood entering the right atrium (mixture of venous blood and treated blood from the ECCO 2 RD, see Fig. 2 ), -C l,CO 2 (l CO 2 /l) is the CO 2 concentration in the lung (in the pulmonary capillaries),
-P I,CO 2 = F I,CO 2 ·(P atm −47) is the inspired CO 2 partial pressure (in mmHg). F I,CO 2 is the inspired fraction of CO 2 (always 0 in our approach), -V L = f r · (V T − V Dead ) is the mean effective ventilation of the lung (in l/min). f r (min −1 ) is the respiratory frequency, V T (l) is the tidal volume and V Dead (l) is the dead space.
After decarboxylation of blood in the lungs, pulmonary blood is mixed with venous blood from the shunt and the concentration of CO 2 in arteries C a,CO 2 (in l O 2 /l) is given by:
The pulmonary gas exchange equations for O 2 are similar to Eqs. 
A.2 Tissues gas exchange
In the tissues, the material balance equations for O 2 and CO 2 are given by [3, 36] : 
A.3 ECCO 2 RD
ECCO 2 RD is considered as a second lung compartment taking a fraction f d of the systemic blood flow Q c in the inferior vena cava and rejecting the corresponding decarboxylated blood in the right atrium (see Figs. 1 and 2) . However, the diffusion of O 2 and CO 2 across the synthetic membrane is less fast than across the lung membrane and the exchange surface is smaller than the alveolar-capillary membrane. As a consequence, the hypothesis of equilibrium between the gas and blood compartments in the device does not hold and the diffusion of O 2 and CO 2 across the synthetic membrane must be taken into account. A sketch of the gas exchanger is shown in Fig. 7 [27]. The geometry is quite complex (it is similar to a cross-flow plate heat exchanger) and several assumptions have to be considered to model this device. The geometry of the device is reduced to one dimension and the gas and blood flows are considered in opposite directions (see for instance [6, 19] . The material balance equations for CO 2 in the gas in the blood are thus given by: The true exchange surface area of the device is given by the manufacturer but is not directly related to the exchange area of the 1-D model. Therefore, a global equivalent diffusion coefficient D CO 2 (l CO 2 /s/mmHg) is considered instead of the product S × D s,CO 2 (as has been done in previous studies [5, 22] ).
The first terms of the left hand sides of Eq. 6 describe the time accumulation of CO 2 in the volumes V D and V d . The two boundary conditions for Eq. 6 give the values of the concentrations at the gas and blood inlets. Since these two inlets correspond to X = 0 and X = 1 respectively, the system of differential equations and boundary conditions must be solved iteratively (note that After crossing the device, the treated blood is mixed with venous blood and the concentration of CO 2 entering the right atrium C vd,CO 2 is given by:
The concentration C vd,O 2 is calculated in the same way.
A.4 Blood chemistry
The relations between partial pressures and total concentrations of gases are really complex in blood. Indeed, O 2 and CO 2 are not only dissolved in blood plasma since they can also be complexed with hemoglobin. In addition, CO 2 is also subject to the hydratation/dehydratation reaction:
which influences the pH.
In the model, the relation between O 2 concentration C O 2 and O 2 partial pressure P O 2 follows the equations of Grodins et al. [12] :
where 
A.5 Parameters of the mathematical model
Many parameters appear in the mathematical model. They are either estimated with experimental measurements or taken from the literature. Table 3 provides a list of all parameters and explain how their values are determined. For identified parameters, the identification procedure is explained in the Section 2.3. Other parameters are directly estimated with a measuring device: the cardiac blood flow is measured with thermodilution technique (PiCCO , Pulsion, Germany) and also with an admittance pressurevolume catheter (Transonic ); the hemoglobin concentration is measured with a blood analyser (RapidPoint500 , Siemens, Germany). Note that the cardiac output is a varying parameter whose changes over time are measured continuously and introduced in the model as an input function of time. The hemoglobin concentration is estimated in arterial and venous blood samples for every pig and the mean of all these values is used.
The parameters taken from the literature are derived from human study. α CO 2 , α O 2 , and K HCO 3 are taken from Rees et al. [30] and the effective volumes V T ,CO 2 , V T ,O 2 , V L,CO 2 , and V T ,O 2 are assumed proportional to the body weight and their values are adapted from [3] (where these parameters are given for a man weighing 75 kg). For the chemical parameters (α CO 2 , α O 2 , and K HCO 3 ), taking values from human studies is reasonable since the human blood is very similar to the pig blood. On the other hand, for the effective volumes, the morphology of humans is quite different than pigs and taking the values adapted from Batzel et al. is a rough approximation. However, the effective volumes influence just the unstable terms of the system. Therefore, this approximation impacts only the transitory terms which is not very important for the goal of this paper.
Finally, some parameters are controlled during the experiments since they are the settings of the ventilator and of the ECCO 2 RD.
Appendix B: decrease of MR O 2 and MR CO 2 with temperature
The detailed analysis of the temperature dependence of metabolism is not the purpose of the present paper since the final goal of our approach is to develop a model to be used in the ICU, where temperature is controlled and kept constant. However, in the experiments to which the model was compared, the temperature of the animals was decreasing. It was thus necessary to take this effect into account to obtain a good validation of the model, but given our final purpose, a rather rough description of the temperature changes is of course sufficient.
The decrease of temperature in the experiments during ECCO 2 RT is illustrated in Fig. 8 for three pigs (for the other pigs, the temperature had not been recorded). Unfortunately, it was not possible to estimate the corresponding decrease of parameters MR O 2 and MR CO 2 . Indeed, the estimation of these parameters requires stabilized (i.e., time independent) data (see Section 2.3), which were not available in the experiments during the ECCO 2 RT. To study the metabolism changes with temperature, we made a retrospective analysis of other experiments carried out in our lab (see [26] ), for which appropriate data were available. The composition of the gas expired out the ventilator has been recorded continuously for two pigs (pig 1 and pig 2). In a stabilized situation, the CO 2 production by the metabolism is equal to the CO 2 extraction by the ventilator and we can write the following equation:
where F E,CO 2 is the end tidal CO 2 volume fraction andV L is estimated from the tidal volume and the respiratory frequency given by the ventilator and an assumed dead space fixed equal to 30% of the tidal volume [14] . Fig. 8 , we can calculate a mean time rate of change for the temperature of the animals used in the experiments, and we found the value 0.0255 • C/min. Finally, from this value and from the value of the metabolism rate of change with temperature, we deduce the following estimation of the time rate of change of metabolism production rates in the experiments: 4.78 × 10 −4 l/min 2 . This value was used in our simulations for all animals.
